BeiGene Market Cap

BeiGene has a market cap or net worth of $18.75 billion as of December 20, 2024. Its market cap has increased by 0.37% in one year.

Market Cap

18.75B

Enterprise Value

17.09B

Revenue

3.35B

Ranking

n/a

PE Ratio

n/a

Stock Price

$14.40

Market Cap Chart

Since February 3, 2016, BeiGene's market cap has increased from 858.74M to 18.75B, an increase of 2,083.71%. That is a compound annual growth rate of 41.49%.

Market Cap History

Date	Market Cap	% Change
Dec 20, 2024	18.75B	-0.18%
Dec 29, 2023	18.79B	-17.76%
Dec 30, 2022	22.84B	-17.96%
Dec 31, 2021	27.84B	18.51%
Dec 31, 2020	23.49B	131.83%
Dec 31, 2019	10.13B	21.77%
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sandoz Group AG	18.23B
Telix Pharmaceuticals Limited	5.18B
Elekta AB (publ)	2.09B
Ryman Healthcare Limited	1.71B
Verano Holdings Corp.	471.76M
Vireo Growth Inc.	126.59M
Medexus Pharmaceuticals Inc.	48.37M

Market Cap Rankings